Dyspepsia Recruiting Phase 3 Trials for Domperidone (DB01184)

Also known as: Indigestion

IndicationStatusPhase
DBCOND0004526 (Dyspepsia)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01696734Domperidone in Treating Patients With Gastrointestinal DisordersTreatment